AstraZeneca could start profiting from its COVID-19 vaccine as soon as July next year, the Financial Times has reported, citing a memo showing the British drugmaker can declare when it considers the pandemic to have ended.
Ciara Lee reports
AstraZeneca could start profiting from its COVID-19 vaccine as soon as July next year, the Financial Times has reported, citing a memo showing the British drugmaker can declare when it considers the pandemic to have ended.
Ciara Lee reports